Feilun Cui
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 2
- Ubiquitin and proteasome pathways 1
-
- Prostate Cancer Treatment and Research 4
- Prostate Cancer Diagnosis and Treatment 2
- Co-authors
- Jianpeng Hu (11 shared papers)Jian Tan (4 shared papers)Yu Fan (6 shared papers)Binbin Hu (1 shared paper)Changfeng Man (3 shared papers)Zhipeng Xu (3 shared papers)Yu Fan (1 shared paper)Liansheng Zhang (1 shared paper)
- Journals
- BMC Cancer (2 papers)Frontiers in Pharmacology (1 paper)Diagnostic Pathology (1 paper)Acta Oto-Laryngologica (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- China
In The Last Decade
Feilun Cui
25 papers receiving 265 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 64
- Pulmonary and Respiratory Medicine 61
- Molecular Biology 136
- Psychiatry and Mental health 21
- Oncology 28
Countries citing papers authored by Feilun Cui
This map shows the geographic impact of Feilun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilun Cui more than expected).
Fields of papers citing papers by Feilun Cui
This network shows the impact of papers produced by Feilun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilun Cui. The network helps show where Feilun Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Feilun Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 33 | |
| 2 | 2019 | 29 | |
| 3 | 2011 | 29 | |
| 4 | 2018 | 28 | |
| 5 | 2018 | 25 | |
| 6 | 2018 | 25 | |
| 7 | 2014 | 15 | |
| 8 | 2022 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2023 | 7 | |
| 12 | 2024 | 6 | |
| 13 | [Effects of laminarin sulphate on the expressions of PTEN and P271kip1 in prostate cancer PC-3 cells]. | 2010 | 6 |
| 14 | 2021 | 5 | |
| 15 | 2021 | 5 | |
| 16 | [Expression of pituitary tumor transforming gene in human renal clear cell carcinoma and its significance]. | 2010 | 4 |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 3 | |
| 20 | [Suppression of invasion and angiogenesis in human prostate cancer PC-3 cells by adenovirus-mediated co-transfer of PTEN and P27]. | 2007 | 3 |
About Feilun Cui
Feilun Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Immunology, having authored 30 papers that have together received 266 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Epigenetics and DNA Methylation (3 papers), Circular RNAs in diseases (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Immune cells in cancer (2 papers), MicroRNA in disease regulation (2 papers), Cancer-related molecular mechanisms research (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (64 citations), Pulmonary and Respiratory Medicine (61 citations), Molecular Biology (136 citations), Psychiatry and Mental health (21 citations) and Oncology (28 citations). Feilun Cui has collaborated with scholars based in China. Frequent co-authors include Jianpeng Hu, Jian Tan, Yu Fan, Binbin Hu, Changfeng Man, Zhipeng Xu, Yu Fan, Liansheng Zhang, Shihe Shao and Zhen Qiu. Their work appears in journals such as BMC Cancer, Frontiers in Pharmacology, Diagnostic Pathology, Acta Oto-Laryngologica and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.